ARTICLE | Clinical News
Jetrea ocriplasmin regulatory update
February 16, 2015 8:00 AM UTC
ThromboGenics said Argentina and Israel approved Jetrea ocriplasmin to treat vitreomacular traction (VMT), including when associated with a macular hole diameter of =400 um. The Alcon Inc. ophthalmic...